Ophthalmology

Top Medical News
Coffee drinkers at high risk of primary open-angle glaucoma
12 May 2022
A recent Mendelian randomization study has provided evidence that increased coffee intake can put individuals at higher risk of developing primary open-angle glaucoma, a study reports.
Diabetic retinopathy in T1DM linked to HbA1c, albuminuria, HDL cholesterol
12 May 2022
The incidence of diabetic retinopathy and its progression in patients with type 1 diabetes mellitus (T1DM) is still high, especially in the presence of high HbA1c, albuminuria, and low high-density lipoprotein (HDL) cholesterol levels, as reported in a study.
Natamycin still best bet for treating fungal keratitis
Jairia Dela Cruz, 11 May 2022
In the treatment of patients with filamentous fungal keratitis, natamycin performs better than chlorhexidine, being associated with more favourable outcomes, including visual acuity, and fewer adverse events, as shown in a study.
Fluocinolone acetonide implant safe, effective in the long run
08 May 2022
A fluocinolone acetonide implant shows good tolerability and safety profile over ≥3 years of follow-up, yielding only predictable and manageable events, according to a study.
UWFA detects more retinal capillary nonperfusion in temporal quadrant
05 May 2022
Ultra-widefield angiography (UWFA) is able to identify more retinal capillary nonperfusion (RCNP) than conventional fundus fluorescein angiography, particularly in the temporal quadrant. Of note, large increases in RCNP over 100 weeks of follow-up seeme to be uncommon.
Machine learning shows potential in detection of age-related macular degeneration
04 May 2022
Existing machine learning classifiers for age-related macular degeneration (AMD) demonstrate promising diagnostic accuracy, reports a recent meta-analysis.
Adalimumab confers favourable long-term outcome in uveitis
Jairia Dela Cruz, 19 Apr 2022
In the treatment of patients with uveitis, adalimumab delivers long-term efficacy while having an acceptable side-effect profile, according to real-world data.
Special Reports
Product Highlight - Bilaxten ODT
16 Mar 2022
Bilastine 10 mg orodispersible tablet
No increased ophthalmic risk with roxadustat treatment in DD CKD-related anaemia
Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Product Highlights
CME Modules